Healthcare artificial intelligence company Tempus AI saw a 14% surge in stock price after FDA clearance for upgraded Tempus Pixel cardiac imaging platform. Company believes this advancement will benefit both its results and medical science. Tempus AI also offers AI-boosted tools for diagnostics like CT scans and X-rays.

The company’s success in cardiac health imaging is promising for the healthcare sector. Tempus AI’s strategic acquisitions and proprietary efforts in AI technology position it as a leader in the industry. The company’s focus on effective deployment of AI in healthcare could lead to continued growth and success.

Stock Advisor did not include Tempus AI in their list of top 10 stocks to buy, but highlighted potential for high returns in their recommended stocks. The advisor’s total average return is 1,066%, significantly outperforming the S&P 500. Investors can access the latest top 10 list by joining Stock Advisor for potential investment opportunities.

Read more at Yahoo Finance: Why Tempus AI Stock Soared Nearly 14% Higher Today